Literature DB >> 21881770

Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.

Bianca Ervatti Gama1, Marcus Vinicius Guimarães Lacerda, Cláudio Tadeu Daniel-Ribeiro, Maria de Fátima Ferreira-da-Cruz.   

Abstract

In Brazil, malaria still remains a clinically important febrile syndrome for local populations and travelers, occurring mostly in the Amazon Basin. This review aims to report the main efforts employed to control this disease since the 1940s and the emergence of Plasmodium falciparum and Plasmodium vivax chemoresistance to chloroquine and sulphadoxine-pyrimethamine among other drugs. Additionally, in vivo, in vitro and molecular studies as well as malaria chemoresistance consequences on disease morbidity and policy treatment guidelines were commented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881770     DOI: 10.1590/s0074-02762011000900020

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  19 in total

Review 1.  Drug resistance in Plasmodium.

Authors:  Kasturi Haldar; Souvik Bhattacharjee; Innocent Safeukui
Journal:  Nat Rev Microbiol       Date:  2018-01-22       Impact factor: 60.633

2.  Single-nucleotide polymorphism and copy number variation of the multidrug resistance-1 locus of Plasmodium vivax: local and global patterns.

Authors:  Rosa del Carmen Miluska Vargas-Rodríguez; Melissa da Silva Bastos; Maria José Menezes; Pamela Orjuela-Sánchez; Marcelo U Ferreira
Journal:  Am J Trop Med Hyg       Date:  2012-09-04       Impact factor: 2.345

Review 3.  Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature.

Authors:  Marcus V G Lacerda; Maria P G Mourão; Márcia A A Alexandre; André M Siqueira; Belisa M L Magalhães; Flor E Martinez-Espinosa; Franklin S Santana Filho; Patrícia Brasil; Ana M R S Ventura; Mauro S Tada; Vanja S C D Couto; Antônio R Silva; Rita S U Silva; Maria G C Alecrim
Journal:  Malar J       Date:  2012-01-09       Impact factor: 2.979

4.  Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether.

Authors:  Stephen G S Vreden; Jeetendra K Jitan; Rakesh D Bansie; Malti R Adhin
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

Review 5.  Genetics of chloroquine-resistant malaria: a haplotypic view.

Authors:  Gauri Awasthi; Aparup Das
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

6.  Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Travel Med Infect Dis       Date:  2013-02-28       Impact factor: 6.211

Review 7.  Malaria in South America: a drug discovery perspective.

Authors:  Luiza R Cruz; Thomas Spangenberg; Marcus V G Lacerda; Timothy N C Wells
Journal:  Malar J       Date:  2013-05-24       Impact factor: 2.979

8.  Use of a colorimetric (DELI) test for the evaluation of chemoresistance of Plasmodium falciparum and Plasmodium vivax to commonly used anti-plasmodial drugs in the Brazilian Amazon.

Authors:  Lilian R Pratt-Riccio; Yonne F Chehuan; Maria José Siqueira; Maria das Graças Alecrim; Cesare Bianco-Junior; Pierre Druilhe; Philippe Brasseur; Maria de Fátima Ferreira-da-Cruz; Leonardo J M Carvalho; Cláudio T Daniel-Ribeiro
Journal:  Malar J       Date:  2013-08-12       Impact factor: 2.979

Review 9.  N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine.

Authors:  Fernanda G Versiani; Maria E Almeida; Luis A Mariuba; Patricia P Orlandi; Paulo A Nogueira
Journal:  Clin Dev Immunol       Date:  2013-09-28

10.  High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.

Authors:  Fernanda G Versiani; Maria E M Almeida; Gisely C Melo; Francivaldo O L Versiani; Patrícia P Orlandi; Luís André M Mariúba; Leidiane A Soares; Luciana P Souza; Antonio A da Silva Balieiro; Wuelton M Monteiro; Fabio T M Costa; Hernando A del Portillo; Marcus V G Lacerda; Paulo A Nogueira
Journal:  Malar J       Date:  2013-08-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.